UPDATE: Oppenheimer Downgrades Aurinia Pharmaceuticals (AUPH) to Perform
Tweet Send to a Friend
(Updated - October 28, 2021 6:42 AM EDT)
Oppenheimer analyst Justin Kim downgraded Aurinia Pharmaceuticals (NASDAQ: AUPH) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Justin Kim downgraded Aurinia Pharmaceuticals (NASDAQ: AUPH) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
